What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
David J. Sugarbaker mostly deals with Surgery, Lung cancer, Mesothelioma, Cancer research and Respiratory disease.
David J. Sugarbaker interconnects Extrapleural Pneumonectomy and Pneumonectomy in the investigation of issues within Surgery.
David J. Sugarbaker has researched Lung cancer in several fields, including Cancer, Adenocarcinoma and Carcinoma.
His study in Carcinoma is interdisciplinary in nature, drawing from both Lung and Mutation frequency.
The concepts of his Mesothelioma study are interwoven with issues in Fluorescence in situ hybridization, Pleural disease, Chemotherapy and Primary tumor.
His Pathology research includes elements of Endothelium and Oncology.
His most cited work include:
- Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses (2194 citations)
- Non–Small Cell Lung Cancer (1231 citations)
- Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781 (950 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Surgery, Mesothelioma, Lung cancer, Internal medicine and Cancer.
The study incorporates disciplines such as Respiratory disease and Extrapleural Pneumonectomy, Pneumonectomy in addition to Surgery.
His Mesothelioma study integrates concerns from other disciplines, such as Pleural disease, Radiology and General surgery.
His Lung cancer research incorporates themes from Stage, Carcinoma, Lung and Adenocarcinoma.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Oncology.
As part of one scientific family, David J. Sugarbaker deals mainly with the area of Pathology, narrowing it down to issues related to the Cancer research, and often Carcinogenesis.
He most often published in these fields:
- Surgery (46.19%)
- Mesothelioma (24.48%)
- Lung cancer (23.33%)
What were the highlights of his more recent work (between 2010-2020)?
- Surgery (46.19%)
- Mesothelioma (24.48%)
- Radiology (16.63%)
In recent papers he was focusing on the following fields of study:
David J. Sugarbaker mainly focuses on Surgery, Mesothelioma, Radiology, Lung cancer and Cancer.
His biological study spans a wide range of topics, including Pneumonectomy, Pleural mesothelioma and Extrapleural Pneumonectomy.
His research integrates issues of Internal medicine, Oncology and Cancer research in his study of Mesothelioma.
Confidence interval and Adenocarcinoma is closely connected to Neoadjuvant therapy in his research, which is encompassed under the umbrella topic of Radiology.
His work in Lung cancer addresses subjects such as Lung, which are connected to disciplines such as Gene expression and Gene expression profiling.
His studies deal with areas such as Quality of life and Multimodal therapy as well as Cancer.
Between 2010 and 2020, his most popular works were:
- The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups (421 citations)
- Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations (392 citations)
- Lobectomy Versus Sublobar Resection for Small (2 cm or Less) Non–Small Cell Lung Cancers (117 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Surgery, Mesothelioma, Radiology, Cancer and Lung cancer are his primary areas of study.
His studies in Surgery integrate themes in fields like Neoadjuvant therapy and Extrapleural Pneumonectomy.
To a larger extent, David J. Sugarbaker studies Pathology with the aim of understanding Mesothelioma.
His Radiology study incorporates themes from Chemotherapy, Adjuvant therapy, Retrospective cohort study and Hodgkin lymphoma.
David J. Sugarbaker has included themes like Quality of life, Multimodal therapy and Intensive care medicine in his Cancer study.
His Lung cancer study combines topics in areas such as Cardiothoracic surgery and Comorbidity.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
